You searched for Antibody candidate - Page 21 of 69

In Depth 22 Jul 2020

Artificial Intelligence: A Superpower in the Fight Against Covid-19

…15,000 potential candidates, including approved as well as investigational drugs. All these drug candidates had previously passed the human safety testing stage. The team can rapidly identify treatment candidates, which…

July 22, 2020 - 8 minutesmins - By David Kirk

News and Trends 24 Jun 2022

Stramsen Biotech to look at 11 plant-based drug candidates

Houston-based biotechnology firm Stramsen Biotech Inc. has announced 11 drug candidates for clinical development. Kefas Mugittu, co-CEO, made the announcement of the plant-based medical candidates. The company said the drugs…

June 24, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 3 Jul 2020

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

…different mRNA vaccine candidates against Covid-19 and the interim results come from the most advanced of the four. All of the candidates consist of delivering mRNA molecules into the body…

July 3, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 8 Jun 2016

12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting

…most common checkpoint inhibitor), treatment with 4SC-202 led to reduction in tumor size. With its huge antibody libraries, MorphoSys is currently in clinical trials with more than 20 candidates. At…

June 8, 2016 - 7 minutesmins - By Denise Neves Gameiro

News and Trends 4 Jul 2023

Exeliom Biosciences closes €24M financing for lead candidate

…to progress the clinical development of Exeliom Biosciences’ lead candidate, EXL01, into two new therapeutic areas: immuno-oncology and infectious diseases. EXL01 is a once daily, potentially first-in-class, microbiome-based immunotherapy containing…

July 4, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 29 Apr 2025

Six biotech companies leading the charge in hemophilia treatment

…on the market can only address one disease subtype because they work by replacing a specific clotting factor. Be Biopharma Technology: Engineered B cell medicines Lead hemophilia candidate: BE-101 Recent…

April 29, 2025 - 10 minutesmins - By Willow Shah-Neville

Best in Biotech 12 Dec 2017

Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017

…fresh start that is 2018 are fast approaching, so let’s get this over and done with: here are 2017’s biggest clinical disappointments. CureVac’s Prostate Cancer Candidate Misses Primary Endpoint The…

December 12, 2017 - 7 minutesmins - By Alex Dale

unity biotechnology anti aging geroscience senolytics

News and Trends 25 Aug 2020

What Does Unity’s Phase II Fail Mean for European Anti-Aging Research?

…has a different cellular target to that of Unity’s lead candidate, and Velabs’ candidates are antibody drugs instead of small molecules. Senolytx is branching out into developing senomorphic drugs —…

August 25, 2020 - 6 minutesmins - By Jonathan Smith

Best in Biotech 20 Jun 2024

CRISPR technology’s next wave: Eight companies to watch in 2024

…to inosine) and RESCUE (cytosine to uracil) systems for RNA editing, enabling targeted genetic modifications. Beam Therapeutics has several key candidates in various stages of development: BEAM-101: Designed to treat…

June 20, 2024 - 11 minutesmins - By Jules Adam

News and Trends 15 Jul 2016

Compugen is Hunting down ‘Hot’ zone Targets for Immuno-Oncology

…candidates discovered by the Company through the use of its unique in silico predictive discovery platforms. Candidates are selected based on on B7/CD28-like immune checkpoint activity, which means they could…

July 15, 2016 - 2 minutesmins - By Joachim Eeckhout

Best in Biotech 5 Sep 2024

Six biotech companies that could revolutionize obesity treatments

…slash drug prices as more and more drugs enter the market. And so are Swiss multinational Roche’s clinical candidates including its once-daily weight loss pill that has shown promise in…

September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 22 Nov 2017

Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout

…of a number of candidates that Galapagos and AbbVie are looking at to form a triple combination therapy. This particular candidate is a corrector drug, meaning it helps to restore…

November 22, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Artificial Intelligence: A Superpower in the Fight Against Covid-19

Stramsen Biotech to look at 11 plant-based drug candidates

Pfizer-BioNTech Covid-19 Vaccine Shows Phase I Promise

12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting

Exeliom Biosciences closes €24M financing for lead candidate

Six biotech companies leading the charge in hemophilia treatment

Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017

What Does Unity’s Phase II Fail Mean for European Anti-Aging Research?

CRISPR technology’s next wave: Eight companies to watch in 2024

Compugen is Hunting down ‘Hot’ zone Targets for Immuno-Oncology

Six biotech companies that could revolutionize obesity treatments

Galapagos Cystic Fibrosis Drug Enters Phase I, Triggering €8.5M Payout

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!